Pharma/Biopharma

A new tumor-modeling platform called a tumor-microenvironment-on-chip can be used to visualize and quantify how different types of cancer cells react differently to the chemotherapy drug doxorubicin
| 3 min read

A new tumor-modeling platform called a tumor-microenvironment-on-chip can be used to visualize and quantify how different types of cancer cells react differently to the chemotherapy drug doxorubicin